These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7291729)

  • 1. Effect of suramin on the activities of degradative enzymes of sphingolipids in rats.
    Constantopoulos G; Rees S; Cragg BG; Barranger JA; Brady RO
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):87-97. PubMed ID: 7291729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential inhibition of beta-hexosaminidase A and beta-hexosaminidase B by suramin.
    Constantopoulos G; Rees S; Cragg BG; Barranger JA; Brady RO
    Biochem Biophys Res Commun; 1981 Aug; 101(4):1345-9. PubMed ID: 6458294
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental animal model for mucopolysaccharidosis: suramin-induced glycosaminoglycan and sphingolipid accumulation in the rat.
    Constantopoulos G; Rees S; Cragg BG; Barranger JA; Brady RO
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3700-4. PubMed ID: 6774343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A lysosomal storage disorder in mice characterized by the accumulation of several sphingolipids.
    Pentchev PG; Gal AE; Boothe AD; Fouks J; Omodeo-Sale F; Brady RO
    Birth Defects Orig Artic Ser; 1980; 16(1):225-30. PubMed ID: 7448355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.
    Sango K; McDonald MP; Crawley JN; Mack ML; Tifft CJ; Skop E; Starr CM; Hoffmann A; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1996 Nov; 14(3):348-52. PubMed ID: 8896570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic studies of glycosphingolipid accumulation in mucopolysaccharidosis IIID.
    Liour SS; Jones MZ; Suzuki M; Bieberich E; Yu RK
    Mol Genet Metab; 2001 Mar; 72(3):239-47. PubMed ID: 11243730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of suramin on adenylate cyclase and protein kinase C.
    Lopez-Lopez R; Langeveld CH; Pizao PE; van Rijswijk RE; Wagstaff J; Pinedo HM; Peters GJ
    Anticancer Drug Des; 1994 Aug; 9(4):279-90. PubMed ID: 7916897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suramin-treated rat as a model of mucopolysaccharidosis. Variation in the reversibility of biochemical and morphological changes among different organs.
    Rees S; Constantopoulos G; Brady RO
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(3):259-72. PubMed ID: 2879381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lysosomal storage diseases, genetic or drug-induced? effect of glycosaminoglycan and sphingolipid disorders on dental tissues].
    Goldberg M; Gritli A; Bloch-Zupan A; Septier D; Lécolle S; Legrand JM; Ruch JV
    C R Seances Soc Biol Fil; 1993; 187(5):596-607. PubMed ID: 8069712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate specificity and inhibitor studies of a membrane-bound ganglioside sialidase isolated from human brain tissue.
    Oehler C; Kopitz J; Cantz M
    Biol Chem; 2002 Nov; 383(11):1735-42. PubMed ID: 12530538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suramin interaction with human alpha-thrombin: inhibitory effects and binding studies.
    Monteiro RQ; Campana PT; Melo PA; Bianconi ML
    Int J Biochem Cell Biol; 2004 Oct; 36(10):2077-85. PubMed ID: 15203120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suramin counteracts the haemostatic disturbances produced by Bothrops jararaca snake venom.
    Fernandes RS; Assafim M; Arruda EZ; Melo PA; Zingali RB; Monteiro RQ
    Toxicon; 2007 Jun; 49(7):931-8. PubMed ID: 17316730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingolipids of transplantable rat nephroma-RA.
    Kandyba AG; Somova OG; Kozlov AM; Zubova ES; Dudnik LB; Alessenko AV; Shvetz VI; Dyatlovitskaya EV
    Biochemistry (Mosc); 2000 Jun; 65(6):703-6. PubMed ID: 10887290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibition of human folylpolyglutamate synthetase by suramin.
    McGuire JJ; Haile WH
    Arch Biochem Biophys; 1996 Nov; 335(1):139-44. PubMed ID: 8914844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suramin analogues as subtype-selective G protein inhibitors.
    Freissmuth M; Boehm S; Beindl W; Nickel P; Ijzerman AP; Hohenegger M; Nanoff C
    Mol Pharmacol; 1996 Apr; 49(4):602-11. PubMed ID: 8609887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sphingolipid level and the activity of their hydrolases in the organs of rats with vitamin A deficiency].
    Leutskii KM; Matsepa RL
    Ukr Biokhim Zh; 1973; 45(1):7-12. PubMed ID: 4348881
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of axonal differentiation by silencing plasma membrane-associated sialidase Neu3 in neuroblastoma cells.
    Valaperta R; Valsecchi M; Rocchetta F; Aureli M; Prioni S; Prinetti A; Chigorno V; Sonnino S
    J Neurochem; 2007 Feb; 100(3):708-19. PubMed ID: 17176265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy.
    Modrak DE
    Methods Mol Med; 2005; 111():183-94. PubMed ID: 15911980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suramin induced ceramide accumulation leads to apoptotic cell death in dorsal root ganglion neurons.
    Gill JS; Windebank AJ
    Cell Death Differ; 1998 Oct; 5(10):876-83. PubMed ID: 10203686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suramin disrupts receptor-G protein coupling by blocking association of G protein alpha and betagamma subunits.
    Chung WC; Kermode JC
    J Pharmacol Exp Ther; 2005 Apr; 313(1):191-8. PubMed ID: 15626724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.